Beiersdorf acquires majority stake in S-Biomedic

Dec 16 (Reuters) – Beiersdorf (BEIG.DE) said on Friday it had acquired a majority stake in Belgian biotechnology company S-Biomedic NV.

S Biomedic is to continue operating on its own under Beiersdorf’s existing microbiome programme, Beiersdorf added in a statement.

The purchase price was not disclosed.

Reporting by Tristan Chabba in Gdansk, editing by Rachel More

Our Standards: The Thomson Reuters Trust Principles.

Read more…

Request a Call Back

Contact Info